Matthew Kirkpatrick to Smoking Cessation
This is a "connection" page, showing publications Matthew Kirkpatrick has written about Smoking Cessation.
Connection Strength
7.866
-
Depression symptom level associates with negative and positive affect and cognitive dysfunction during a smoking cessation quit attempt. J Affect Disord. 2026 Jan 01; 392:120237.
Score: 0.750
-
Sex differences in cigarette smoking following a mindfulness-based cessation randomized controlled trial. Addict Behav. 2025 Jan; 160:108177.
Score: 0.702
-
Effect of a mindfulness training app on a cigarette quit attempt: an investigator-blinded, 58-county randomized controlled trial. JNCI Cancer Spectr. 2023 10 31; 7(6).
Score: 0.660
-
Implementation planning for equitable tobacco treatment services: a mixed methods assessment of contextual facilitators and barriers in a large comprehensive cancer center. Transl Behav Med. 2023 08 11; 13(8):539-550.
Score: 0.650
-
Associations of DHEA(S) with negative and positive affect in people who smoke daily with elevated and low depression symptoms: A pilot laboratory study. Addict Behav. 2023 11; 146:107801.
Score: 0.645
-
Emotion regulation expectancies and smoking cessation factors: A daily diary study of California adults who smoke cigarettes during a practice quit attempt. Drug Alcohol Depend. 2023 04 01; 245:109810.
Score: 0.628
-
Interactive associations between abstinence plans and romantic partner conflict and support with cigarette smoking. Drug Alcohol Depend. 2023 02 01; 243:109756.
Score: 0.622
-
Effects of cigarette abstinence on negative and positive affect by depression symptom levels: A lab study. J Affect Disord. 2022 06 15; 307:163-170.
Score: 0.590
-
Interactions between daily abstinence plans and approach/avoidance motivation on cigarette smoking in pre-quit smokers. Exp Clin Psychopharmacol. 2022 Oct; 30(5):666-672.
Score: 0.554
-
Impact of self-efficacy on daily intention to not smoke. Addict Behav. 2021 07; 118:106877.
Score: 0.548
-
Initial application of a human laboratory model for estimating the motivational substitutability of e-cigarettes for combustible cigarettes. Exp Clin Psychopharmacol. 2019 Apr; 27(2):125-135.
Score: 0.474
-
Effects of intranasal oxytocin on cigarette withdrawal and smoking in the laboratory: Differences by sex and social functioning traits. Exp Clin Psychopharmacol. 2024 Dec; 32(6):717-727.
Score: 0.173
-
Association of depression symptom level with smoking urges, cigarette withdrawal, and smoking reinstatement: A preliminary laboratory study. Drug Alcohol Depend. 2022 03 01; 232:109267.
Score: 0.146
-
Topics of Nicotine-Related Discussions on Twitter: Infoveillance Study. J Med Internet Res. 2021 06 07; 23(6):e25579.
Score: 0.140
-
Effectiveness of transdermal nicotine patch in premenopausal female smokers is moderated by within-subject severity of negative affect and physical symptoms. Psychopharmacology (Berl). 2020 Jun; 237(6):1737-1744.
Score: 0.128
-
Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers. J Abnorm Psychol. 2018 Oct; 127(7):683-694.
Score: 0.115
-
Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory. Neuropsychopharmacology. 2018 03; 43(4):828-837.
Score: 0.108
-
Anhedonia and Abstinence as Predictors of the Subjective Pleasantness of Positive, Negative, and Smoking-Related Pictures. Nicotine Tob Res. 2017 Jun 01; 19(6):743-749.
Score: 0.106
-
Premenstrual symptoms and smoking-related expectancies. Addict Behav. 2016 Jun; 57:38-41.
Score: 0.096
-
Conceptualizing Health Behaviors as Acute Mood-Altering Agents: Implications for Cancer Control. Cancer Prev Res (Phila). 2020 04; 13(4):343-350.
Score: 0.032